Streetbeat News

BAYRY

Bayer AG

https://www.bayer.de/

CEO

Werner Baumann

Industry

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Open

5.42

Mkt cap

21B

Volume

499K

High

5.42

P/E Ratio

-15.79

52-wk high

11.33

Low

5.32

Div yield

0.00

52-wk low

5.32

Roivant Sciences Ltd. has launched a new subsidiary, Pulmovant, to develop and commercialize the pulmonary hypertension drug mosliciguat, in-licensed from Bayer AG. The drug has shown promising results in reducing pulmonary vascular resistance in trials. Roivant's stock is down 1.88% following the announcement.

Portfolio Pulse from Vandana Singh

September 10, 2024 | 6:21 pm

BridgeBio Pharma's stock rose after presenting positive data from its Phase 3 study of acoramidis for ATTR-CM at the ESC 2024. The company has submitted a marketing application to the FDA, with a decision expected by November 29, and to the European Medicines Agency, with a decision in 2025. BridgeBio has also partnered with Bayer for commercialization in Europe.

Portfolio Pulse from Vandana Singh

August 30, 2024 | 5:10 pm

An Australian judge dismissed a class action lawsuit alleging Bayer's Roundup weedkiller causes blood cancer, marking a significant victory for Bayer. The ruling supports Bayer's stance on the safety of its glyphosate-based products. Despite this win, Bayer still faces over 50,000 claims in the U.S.

Portfolio Pulse from Vandana Singh

July 25, 2024 | 6:35 pm

A Pennsylvania judge reduced a $2.25 billion verdict against Bayer AG to $400 million in a case involving cancer claims linked to Roundup weedkiller. Bayer plans to appeal the decision, while the plaintiff's legal team seeks to reinstate the original verdict. Despite numerous studies indicating glyphosate's safety, Bayer faces extensive legal challenges and over 50,000 pending claims.

Portfolio Pulse from Vandana Singh

June 05, 2024 | 2:06 pm

European equities closed higher on Monday, driven by expectations of an imminent ECB rate cut. Key ECB members made statements supporting a rate cut in June. The euro inched higher, and major European indices saw gains. Notable stock movers included RWE AG, Bayer AG, Volkswagen AG, Enel, Iberdrola, Eni, Novo Nordisk, LVMH, ASML, Stellantis, Ferrari, and UBS.

Portfolio Pulse from Piero Cingari

May 27, 2024 | 5:55 pm

Cencora Inc (NYSE:COR) has notified individuals about a data breach that occurred in February, compromising sensitive medical information. The breach involved data obtained through partnerships with pharmaceutical companies such as AbbVie Inc (NYSE:ABBV), Acadia Pharmaceuticals Inc (NASDAQ:ACAD), Bayer AG (OTC:BAYZF, OTC:BAYRY), Novartis AG (NYSE:NVS), and Regeneron Pharmaceuticals Inc (NASDAQ:REGN). The incident is part of a series of cyberattacks targeting the U.S. healthcare sector.

Portfolio Pulse from Vandana Singh

May 24, 2024 | 4:00 pm

Pfizer, AstraZeneca, Sanofi, and other pharmaceutical companies are investing heavily in France to expand their operations. Pfizer and AstraZeneca will invest nearly $1 billion combined, while Sanofi will invest $1.1 billion. Other companies like AbbVie, Novartis, and Kenvue are also increasing their presence in France. Additionally, Mainz Biomed is expected to unveil breakthrough early cancer detection results in the US.

Portfolio Pulse from Upwallstreet

May 16, 2024 | 12:51 pm

AI is significantly impacting the pharmaceutical industry, from drug discovery to marketing, with Alphabet Inc's Google DeepMind developing AlphaFold 3, an AI model that predicts the structure of biological molecules. McKinsey reports AI could generate $60 billion-$110 billion annually for the industry, speeding up drug discovery and development. Collaborations like Bayer AG and Google Cloud are developing AI solutions for healthcare. Key players include Nvidia, Intel, IBM, Google, GE, Microsoft, Medtronic, Micron Technology, Amazon Web Services, and Siemens Healthineers.

Portfolio Pulse from Vandana Singh

May 10, 2024 | 6:49 pm

Bayer AG's Monsanto unit won a legal victory as a Washington state appeals court overturned a $185 million verdict related to chemical contamination at a school. This decision, marking the company's second major legal win recently, involved a lawsuit from 2021 where three teachers claimed brain damage from exposure to PCBs, banned chemicals Monsanto produced until 1977. The court ruled the lower court improperly applied Missouri laws, allowing claims to be filed decades later. Bayer faces around 200 similar claims, and this ruling could influence future trials and Bayer's financial exposure in PCB contamination claims, potentially surpassing $2.5 billion.

Portfolio Pulse from Vandana Singh

May 02, 2024 | 5:38 pm

CNBC's 'Halftime Report Final Trades' featured recommendations for Nasdaq, Inc. (NDAQ), Alphabet Inc. (GOOG/GOOGL), Spotify Technology S.A. (SPOT), Teck Resources Limited (TECK), and The Charles Schwab Corporation (SCHW). Analyst upgrades and collaborations were highlighted for some, along with upcoming earnings reports and price target adjustments.

Portfolio Pulse from Avi Kapoor

April 10, 2024 | 1:14 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.